Gallbladder bile composition in patients with Crohn’s disease

Table 5 Data on healthy subjects treated with ursodeoxycholic acid (UDCA)

Patients	Sex	Age(yr)	BMI	Cholesterol saturation (%)		Cholesterol(molar %)		Bile acids(molar %)		UDCA i(%)		Bile acids(mmol/mL)		Bilirubin(mmol/L)		Bilirubin/bileacids (mmol/mol)
1	F	39	22.2	103	31	6.6	1.7	74.5	82.8	0.0	49.9	57.1	100.9	490	1058	8.6	10.5
2	F	40	24.4	74	38	4.8	2.4	75.8	79.2	0.0	65.3	92.8	95.6	1466	571	15.8	6.0
3	F	30	26.8	116	46	9.1	3.4	65.8	72.7	0.0	-	75.4	65.8	1031	798	13.7	12.1
4	F	58	26.3	32	42	2.4	2.8	71.7	76.1	0.0	55.8	117.8	73.6	1265	667	10.7	9.1
5	M	33	29.4	125	51	7.4	3.8	76.2	71.4	5.2	55.1	52.1	117.4	1045	1111	20.0	9.5
6	M	30	24.0	104	60	6.1	3.7	77.6	78.2	0.0	66.5	97.9	32.1	1301	418	13.3	13.0
7	M	34	24.9	128	38	8.9	2.5	70.5	76.7	0.0	54.3	52.3	26.3	993	375	19.0	14.3
8	M	73	26.2	118	55	8.9	4.3	67.5	68.6	0.0	35.7	31.0	61.9	1168	1497	37.7	24.2
9	M	49	23.2	77	79	5.6	4.9	71.3	77.7	0.0	41.3	33.5	12.8	662	365	19.8	28.5
10	M	55	24.3	135	77	9.8	4.9	68.6	76.7	0.0	69.7	16.4	8.5	568	197	34.5	23.3
Mean		44	25.2	101	52b	7.0	3.4b	72.0	76.0a	0.5	54.8b	62.6	59.5	999	706	19.3	15.1
SE		4.5	0.7	10	5	0.7	0.3	1.26	1.3	0.5	3.8	10.3	12.1	104	130	3.1	2.4

A = before UDCA feeding; B = after UDCA feeding;

^aP < 0.05,

^bP < 0.01 vs before UDCA feeding.